ResMed Inc.
RMD
$277.05
$3.241.18%
NYSE
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 4.36% | 0.75% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 4.36% | 0.75% | |||
| Cost of Revenue | 0.13% | -1.01% | |||
| Gross Profit | 7.18% | 1.97% | |||
| SG&A Expenses | 8.08% | 1.53% | |||
| Depreciation & Amortization | 16.12% | -1.83% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.00% | 0.07% | |||
| Operating Income | 7.11% | 2.16% | |||
| Income Before Tax | 9.66% | -0.15% | |||
| Income Tax Expenses | 48.80% | -28.56% | |||
| Earnings from Continuing Operations | 4.02% | 5.93% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 4.02% | 5.93% | |||
| EBIT | 7.11% | 2.16% | |||
| EBITDA | 10.82% | 1.40% | |||
| EPS Basic | 4.19% | 5.99% | |||
| Normalized Basic EPS | 9.46% | 0.92% | |||
| EPS Diluted | 4.07% | 5.98% | |||
| Normalized Diluted EPS | 9.41% | 1.03% | |||
| Average Basic Shares Outstanding | -0.17% | -0.06% | |||
| Average Diluted Shares Outstanding | -0.12% | -0.18% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | -0.04% | -0.06% | |||